SCHEMBL31421207

SCHEMBL31421207

COc1ccc(C[C@@H]2[C@H](OC(=O)NCCCCO)[C@@H](OC(=O)OC(C)(C)C)CN2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ TDP1 Q9NUW8 1/20 0.36
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ SMN1; SMN2 Q16637 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ TP53 P04637 2/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ MMP2 P08253 1/20 0.34
▸ MMP9 P14780 1/20 0.34
▸ BRD4 O60885 2/20 0.34
▸ MEN1 O00255 2/20 0.34
▸ KMT2A Q03164 2/20 0.34
▸ CXCR3 P49682 1/20 0.34
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31421000 0.99 TDP1 (0.38) LMNAALDH1A1TDP1CYP3A4CYP2C19
SCHEMBL31420789 0.98 LMNA (0.39) LMNAALDH1A1TDP1CYP3A4CYP2C19
SCHEMBL31421302 0.94 ALDH1A1 (0.40) LMNAALDH1A1CYP3A4CYP2C19SMN1; SMN2
SCHEMBL31420897 0.93 LMNA (0.41) LMNAALDH1A1CYP3A4CYP2C19SMN1; SMN2
SCHEMBL31420569 0.91 LMNA (0.42) LMNAALDH1A1CYP3A4CYP2C19SMN1; SMN2
SCHEMBL31420613 0.90 LMNA (0.38) LMNAALDH1A1CYP3A4CYP2C19SMN1; SMN2
SCHEMBL31421049 0.90 LMNA (0.38) LMNAALDH1A1CYP3A4CYP2C19ABCB1
SCHEMBL31420654 0.90 LMNA (0.39) LMNAALDH1A1CYP3A4CYP2C19SMN1; SMN2
SCHEMBL31420930 0.90 GHSR (0.36) LMNAALDH1A1CYP3A4CYP2C19ABCB1
SCHEMBL31421424 0.90 LMNA (0.42) LMNAALDH1A1CYP3A4CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-04-24 — — US disclosed
WO-2025064718-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129021-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS LMNA 3037/4885ALDH1A1 2630/4885TDP1 3388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback